Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Biotech
CDMO Catalent strengthens ADC pipeline with $10M Lisata pact
Catalent has continued its foray into the ADC space, this time penning a $10 million biobucks pact to evaluate Lisata’s tumor drug.
James Waldron
Oct 9, 2025 7:45am
Turbine looks to turbocharge AstraZeneca's ADC discovery
Oct 9, 2025 6:00am
Sutro loses 3rd of workforce in 2nd round of layoffs this year
Sep 30, 2025 4:16am
Genmab discards ADC from $1.8B ProfoundBio buy
Sep 16, 2025 10:33am
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
Sep 8, 2025 11:00am
Daiichi, Merck rev up for accelerated approval filing
Sep 7, 2025 10:45am
